Synonyms |
|
Carbohydrate Antigen
15-3
|
Clinical
Indications |
|
Serum
CA15-3 is raised in breast and other adenocarcinomas,
especially with distant metastasis. Levels are rarely raised
in patients with localised breast cancer.
|
Request Form |
|
Combined Pathology Blood form
(Yellow/Black)
|
Availability |
|
Analysed by referral laboratory
if specific criteria met.
|
Specific
Criteria |
|
Monitoring
treatment of patients with advanced breast cancer.
|
Turnaround
Time |
|
1 week
|
Specimen |
|
Serum
|
Volume |
|
1 ml
|
Container |
|
Yellow top (SST) tube
|
Lab. Handling |
|
Aliquot and store at 4C.
(SASOD & send; TMND & save)
|
Causes for
Rejection |
|
Not meeting specific criteria for
analysis.
|
Reference
Range |
|
Less than
25 kU/l.
|
Half-life
in Serum |
|
Unknown
|
|
Interpretation |
|
CA15-3 levels may be raised in
benign liver disease and possibly benign breast disease.
Elevations are seen in a number of carcinomas e.g. stomach,
colon, gall bladder, pancreas, oesophagus, liver and lung.
|